-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Life Sciences
-
Healthcare
Life Sciences
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences
Healthcare
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREU.S. BLOGS
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MORE
Launch Excellence, the U.S. Edition: The Rewrite of the Business of Launch – Optimize
"Aligning legislative requirements, payer expectations regarding pricing and evidence, and meeting patients’ needs is now crucial for successful launches.
Learn moreFact Sheet
IQVIA's Provider Medicare Part B
Complete visibility into Fee-for-Service (FFS) Medicare Part B claims activity
May 24, 2024
The pipeline of pharmaceutical products covered under Medicare Part B continues to grow and diversify at a rapid rate, yet for many, it is difficult to generate timely, comprehensive, and competitive market insights without complete visibility into the FFS Medicare Part B channel. These information blind spots directly impact the ability to develop actionable and innovative product and market access strategies.
To solve this problem, IQVIA's Provider Medicare Part B offering provides clients with 100% of professional FFS Durable Medical Equipment ("DME") and non-DME Medicare Part B claims activity with the shortest reporting turnaround time in the industry.
Read the fact sheet to learn more.
To solve this problem, IQVIA's Provider Medicare Part B offering provides clients with 100% of professional FFS Durable Medical Equipment ("DME") and non-DME Medicare Part B claims activity with the shortest reporting turnaround time in the industry.
Read the fact sheet to learn more.